Thymomas are among the most common tumors of the anterior mediastinum. However, considered in the context of the entire spectrum of malignancies, thymomas are unusual neoplasms. It is important to note that thymoma does not represent the benign counterpart of thymic carcinoma, nor is thymic carcinoma the malignant counterpart of thymoma. These two neoplasms, thymoma and thymic carcinoma, represent two different clinicopathological entities, which have been shown to be associated with different clinical outcomes. It is also important to point out that these two conditions may be treated differently depending on the clinical circumstances at the time of diagnosis.
Over the last two decades, controversy has arisen over several views that have been presented on the histological classification, staging, treatment, and clinical behavior of thymomas. As more knowledge is gathered from the different specialties involved in the treatment of patients with thymomas, some views on this subject are likely to be upheld while others will not be, with the result that patients with this neoplasm will receive better care. However, it is important to note that due to the rarity of thymomas, a concentrated experience with a large number of cases is difficult to assemble.
Although the symptomatology that patients with thymoma exhibit on presentation is varied, it is worthwhile highlighting the association of thymomas with paraneoplastic syndromes. Perhaps the most important of these syndromes, or at least one that appears to be among those most frequently associated with thymoma, is myasthenia gravis. Approximately 10% to 15% of patients with myasthenia gravis have thymoma; conversely, about 40% of patients with thymoma have an associated paraneoplastic syndrome, of which myasthenia gravis is among the most common. Other paraneoplastic syndromes seen in patients with thymoma include limbic encephalitis, neuromyotonia, stiff person syndrome, myotonic dystrophy, and polymyositis. Thymoma patients may also have a wide spectrum of associated non-neurologic conditions, including myocarditis, graft-versus-host disease, hypogammaglobulinemia, pure red cell aplasia, intestinal pseudo-obstruction, mixed connective tissue disease, thyroiditis, and many more.The prognosis of patients with thymoma is closely linked to the underlying condition.
Patients affected with thymoma may also present with signs and symptoms unrelated to any underlying condition, including such nonspecific symptoms as chest pain, cough, dyspnea, and other symptoms of mediastinal compression.When symptoms such as these are seen, the initial study to use in evaluation of the patient is chest radiography. Chest imaging will disclose the presence of an anterior mediastinal mass, which can be further analyzed using more advanced studies, such as chest CT, a procedure that provides more specific information regarding the circumscription or invasive nature of the neoplasm.
1. Tormoehlen LM, Pascuzzi RM. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin N Am. 2008;22:509-26.
2. Rosado-de-Christenson ML, Strollo DC, Marom EM. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin N Am. 2008;22:409-31.
3. Bernatz PE, Harrison EG, Claggett OT. Thymoma. A clinicopathologic study. J Thorac Cardiovasc Surg. 1961;42:424-44.
4. Bernatz PE, Khonsari S, Harrison EG, et al. Thymomas: factors influencing prognosis. Surg Clin North Am. 1973;53:885-92.
5. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol. 1985;
6. Salyer WR, Eggleston JC. Thymoma: a clinical and pathological study of 65 cases. Cancer. 1976;37:229-49.
7. Moran CA, Suster S. On the histologic heterogeneity of thymic epithelial neoplasms: impact of sampling in subtyping and classification of thymoma. Am J Clin Pathol. 2000;114:760-6.
8. Quintanilla-Martinez L, Wilkins EW, Choi N, et al. Thymoma: histologic subclassification is an independent prognostic factor. Cancer. 1994;74:606-17.
9. Rosai J. Histological typing of tumours of the thymus. 2nd ed. Berlin, Germany: Springer; 1999.
10. Travis WD, Brambilla E, Müller-Hermelink HK, et al eds. WHO classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon, France: IARC Press; 2004.
11. Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma: a novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol. 1999;111:826-33.
12. Moran CA, Kalhor N, Suster S. Invasive spindle cell thymomas (WHO type A): a clinicopathologic correlation of 41 cases. Am J Clin Pathol. 2010;134:793-8.
13. Moran CA, Weissferdt A, Kalhor N, et al. Thymoma I. A clinicopathologic correlation of 250 cases with emphasis on the World Health Organization Schema. Am J Clin Pathol. 2012;137:444-50.
14. Bergh NP, Gatzinsky P, Larsson S, et al. Tumors of the thymus and thymic region, I: clinicopathological studies on thymomas. Ann Thorac Surg. 1978;25:91-8.
15. Curran WJ, Kornstein MJ, Brooks JJ, et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988;6:1722-7.
16. Gamondes JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg. 1991;5:124-31.
17. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node-metastasis classification of thymoma. Cancer. 1991;68:1984-7.
18. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymoma with special reference to their clinical stages. Cancer. 1981;48:2485-92.
19. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994;44:359-67.
20. Moran CA, Walsh G, Suster S, Kaiser L. Thymoma II. A clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol. 2012;137:451-61.
21. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991;51:152-6.
22. Zhang H, Lu N, Wang M, et al. Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases. Chin Med J (Engl). 1999;112:136-8.
23. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation, therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer. 2004;44:369-79.
24. Ridley GJ, Huang J. Induction therapy for locally advanced thymoma. J Thorac Oncol. 2010;
25. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg. 2003;76:1866-72.
26. Wright CD, Choi NC, Wain JC, et al. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg. 2008;85:385-9.
27. Berruti A, Borasio P, Roncari A, et al. Neoadjuvant chemotherapy with Adriamycin, cisplatin, vincristine, and cyclophosphamide (ADOC) in invasive thymomas: results in six patients. Ann Oncol. 1993;4:429-31.
28. Giaccone G, Wilmink H, Paul MA, et al. Systemic treatment of malignant thymoma: a decade experience at a single institution. Am J Clin Oncol. 2006;29:336-44.
29. Lemma GL, Lee JW, Aisner SC, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011;29:2060-5.
30. Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer. 1991;68:706-13.
31. Lucchi M, Ambrogi MC, Duranti L, et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg. 2005;79:
32. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg. 1993;106:543-9.
33. Moran CA, Suster S. Thymomas with prominent hemorrhagic and necrotic changes: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2001; 25:1086-90.